{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:03:40Z","timestamp":1790949820534,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jneuroim.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T15:53:41Z","timestamp":1307548421000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood\u2013brain barrier"],"prefix":"10.1016","volume":"236","author":[{"given":"Takafumi","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiharu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.04.009_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(03)00006-7","article-title":"Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes","volume":"136","author":"Avolio","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0065-2776(08)60509-X","article-title":"Interleukin-8 and related chemotactic cytokines\u2013CXC and CC chemokines","volume":"55","author":"Baggiolini","year":"1994","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1352458508099482","article-title":"Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis","volume":"15","author":"Benesova","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(96)00210-X","article-title":"Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor","volume":"74","author":"Clements","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.156.1.1","article-title":"Matrix metalloproteinases in immunity","volume":"156","author":"Goetzl","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"Ishizu","year":"2005","journal-title":"Brain"},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2011.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/122.8.1579","article-title":"Differential expression of matrix metalloproteinases in bacterial meningitis","volume":"122","author":"Kieseier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","article-title":"Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum","volume":"20","author":"Kinoshita","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-5728(97)00247-6","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid","volume":"84","author":"Kolb","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0060","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1172\/JCI118286","article-title":"IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes","volume":"96","author":"Lacraz","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-510X(83)90086-2","article-title":"In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement","volume":"59","author":"Lassmann","year":"1983","journal-title":"J. Neurol. Sci."},{"issue":"Pt 2","key":"10.1016\/j.jneuroim.2011.04.009_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/122.2.191","article-title":"Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study","volume":"122","author":"Lee","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0075","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"Pt 12","key":"10.1016\/j.jneuroim.2011.04.009_bb0085","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/121.12.2327","article-title":"Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis","volume":"121","author":"Leppert","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1191\/1352458502ms800oa","article-title":"Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis","volume":"8","author":"Liuzzi","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02821717","article-title":"Extracellular matrix degradation by metalloproteinases and central nervous system diseases","volume":"19","author":"Lukes","year":"1999","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-9525(90)90126-Q","article-title":"Metalloproteinases and their inhibitors in matrix remodeling","volume":"6","author":"Matrisian","year":"1990","journal-title":"Trends Genet."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/138920108783497631","article-title":"Matrix metalloproteinase-9\/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis","volume":"9","author":"Muroski","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0945-053X(97)90025-1","article-title":"Relating matrix metalloproteinase structure to function: why the \u201chemopexin\u201d domain?","volume":"15","author":"Murphy","year":"1997","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.62.1.144","article-title":"Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica","volume":"62","author":"Nakashima","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0130","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuroscience.2004.07.055","article-title":"The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models","volume":"129","author":"Nicchia","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0135","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","article-title":"A case of NMO seropositive for aquaporin-4 antibody more than 10years before onset","volume":"72","author":"Nishiyama","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1189\/jlb.69.6.851","article-title":"Gelatinase B functions as regulator and effector in leukocyte biology","volume":"69","author":"Opdenakker","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0145","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"Piddlesden","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1165\/ajrcmb.20.3.3311","article-title":"Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators","volume":"20","author":"Pugin","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","article-title":"The cell biology of the blood\u2013brain barrier","volume":"22","author":"Rubin","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00286763","article-title":"Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases","volume":"15","author":"Sopata","year":"1995","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1620\/tjem.210.307","article-title":"Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica","volume":"210","author":"Takahashi","year":"2006","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0170","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ana.410320212","article-title":"Interferon-gamma potentiates antibody-mediated demyelination in vivo","volume":"32","author":"Vass","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0185","first-page":"99","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int. MS J."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0190","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2011.04.009_bb0200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281100124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281100124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:16:18Z","timestamp":1759047378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281100124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S016557281100124X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.04.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood\u2013brain barrier","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}